BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25223536)

  • 1. Association between circulating FGF23, α-Klotho, and left ventricular diastolic dysfunction among patients with preserved ejection fraction.
    Okamoto Y; Fujita S; Morita H; Kizawa S; Ito T; Sakane K; Sohmiya K; Hoshiga M; Ishizaka N
    Heart Vessels; 2016 Jan; 31(1):66-73. PubMed ID: 25223536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between circulating fibroblast growth factor 23, α-Klotho, and the left ventricular ejection fraction and left ventricular mass in cardiology inpatients.
    Shibata K; Fujita S; Morita H; Okamoto Y; Sohmiya K; Hoshiga M; Ishizaka N
    PLoS One; 2013; 8(9):e73184. PubMed ID: 24039882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages.
    Tanaka S; Fujita S; Kizawa S; Morita H; Ishizaka N
    PLoS One; 2016; 11(7):e0156860. PubMed ID: 27400031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
    Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum levels of FGF23 and α-Klotho with glomerular filtration rate and proteinuria among cardiac patients.
    Ozeki M; Fujita S; Kizawa S; Morita H; Sohmiya K; Hoshiga M; Ishizaka N
    BMC Nephrol; 2014 Sep; 15():147. PubMed ID: 25200959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 23 and Klotho as cardiovascular risk factors in heart transplant recipients.
    Przybylowski P; Wasilewski G; Janik L; Kozlowska S; Nowak E; Malyszko J
    Transplant Proc; 2014 Oct; 46(8):2848-51. PubMed ID: 25380933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlations of FGF23 and Klotho with cardiovascular injury in chronic kidney disease patients].
    Gan L; Zhou Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 42(9):1058-1065. PubMed ID: 28989152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis.
    Shimamura Y; Hamada K; Inoue K; Ogata K; Ishihara M; Kagawa T; Inoue M; Fujimoto S; Ikebe M; Yuasa K; Yamanaka S; Sugiura T; Terada Y
    Clin Exp Nephrol; 2012 Oct; 16(5):722-9. PubMed ID: 22457086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor-23 and cardiac structure and function.
    Agarwal I; Ide N; Ix JH; Kestenbaum B; Lanske B; Schiller NB; Whooley MA; Mukamal KJ
    J Am Heart Assoc; 2014 Feb; 3(1):e000584. PubMed ID: 24525546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex Differences in Heart Failure With Preserved Ejection Fraction Reflected by B-type Natriuretic Peptide Level.
    Harada E; Mizuno Y; Kugimiya F; Shono M; Maeda H; Yano N; Yasue H
    Am J Med Sci; 2018 Oct; 356(4):335-343. PubMed ID: 30360801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potential application of fibroblast growth factor 23-klotho axis in chronic kidney disease].
    Lacroix JS; Urena-Torres P
    Nephrol Ther; 2020 Mar; 16(2):83-92. PubMed ID: 31843356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients.
    Silva AP; Mendes F; Carias E; Gonçalves RB; Fragoso A; Dias C; Tavares N; Café HM; Santos N; Rato F; Leão Neves P; Almeida E
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Serum Uric Acid Independently Associated With Left Ventricular Mass Index, Ejection Fraction, and B-Type Natriuretic Peptide Among Female and Male Cardiac Patients?
    Yamauchi Y; Fujita SI; Shibata K; Morita H; Ito T; Sohmiya K; Hoshiga M; Ishizaka N
    Int Heart J; 2017 Aug; 58(4):562-569. PubMed ID: 28701671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Diastolic Dysfunction with N-terminal Pro-B-type Natriuretic Peptide Level in Heart Failure Patients with Preserved Ejection Fraction.
    Islam MN; Chowdhury MS; Paul GK; Debnath RC; Shakil SS
    Mymensingh Med J; 2019 Apr; 28(2):333-346. PubMed ID: 31086148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Klotho, fibroblast growth factor-23, and the renin-angiotensin system - an analysis from the PEACE trial.
    Bergmark BA; Udell JA; Morrow DA; Jarolim P; Kuder JF; Solomon SD; Pfeffer MA; Braunwald E; Sabatine MS
    Eur J Heart Fail; 2019 Apr; 21(4):462-470. PubMed ID: 30773798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum uric acid is associated with cardiac diastolic dysfunction among women with preserved ejection fraction.
    Nogi S; Fujita S; Okamoto Y; Kizawa S; Morita H; Ito T; Sakane K; Sohmiya K; Hoshiga M; Ishizaka N
    Am J Physiol Heart Circ Physiol; 2015 Sep; 309(5):H986-94. PubMed ID: 26209055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction.
    Chou RH; Huang PH; Hsu CY; Chang CC; Leu HB; Huang CC; Chen JW; Lin SJ
    Sci Rep; 2016 Sep; 6():33953. PubMed ID: 27650781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
    Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender Specific Association between Serum Fibroblast Growth Factor 23/α-Klotho and Coronary Artery and Aortic Valve Calcification.
    Morita H; Takeda Y; Fujita S; Okamoto Y; Sakane K; Teramoto K; Ozeki M; Tasaki R; Kizawa S; Sohmiya K; Hoshiga M; Ishizaka N
    J Atheroscler Thromb; 2015; 22(12):1338-46. PubMed ID: 26279337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced diurnal variation of heart rate is associated with increased plasma B-type natriuretic peptide level in patients with atrial fibrillation.
    Kamikawa S; Miyoshi T; Doi M; Orita N; Sangawa M; Nakatsu T; Noguchi Y; Hirohata S; Kusachi S; Nakamura K; Ito H
    Clin Cardiol; 2013 Jul; 36(7):394-400. PubMed ID: 23585345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.